Legend Biotech Corporation ( LEGN) - Key Metrics
LEGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $4.14 | $0.36 | -$0.22 | -$0.22 |
| 2026Q1 | $1.65 | -$0.29 | -$0.46 | -$0.60 |
| 2025Q4 | $1.66 | -$0.17 | -$0.57 | -$0.69 |
| 2025Q3 | $1.51 | -$0.22 | $0.16 | $0.13 |
| 2025Q2 | $1.39 | -$0.68 | -$0.07 | -$0.12 |
LEGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 20.06 |
| 2026Q1 | 0% | -15.08 |
| 2025Q4 | 0% | -31.97 |
| 2025Q3 | 0% | -38.82 |
| 2025Q2 | 0% | -13.05 |
LEGN
Price: $20.37
52 week price:
Earnings Per Share: -0.49 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 302700
Market Capitalization: 3.9 billion